KCM
MIRM icon

Kodai Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Kodai Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$2.36M Buy
+52,430
New +$2.47M 0.09% 123

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kodai Capital Management's MIRM Position: Q1 2025 in Review

Kodai Capital Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q1 2025: 52,430 shares worth $2.36M. The stake represents 0.09% of the portfolio and ranks #123 among its holdings.

214 funds tracked by Wall St. Rank hold MIRM as of Q1 2025.

  • Kodai Capital Management held 52,430 shares of Mirum Pharmaceuticals worth $2.36M as of Q1 2025.
  • Mirum Pharmaceuticals was a new Kodai Capital Management position in Q1 2025.
  • Mirum Pharmaceuticals made up 0.09% of Kodai Capital Management's portfolio in Q1 2025, its #123 holding.
  • 214 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2025.

Based on Kodai Capital Management's 13F filing for Q1 2025, filed 15 May 2025.